Tiragolumab Biosimilar - Anti-TIGIT Antibody - BSA and Azide free
Description
Human monoclonal antibody to TIGIT. Research grade Tiragolumab biosimilar.
Applications
ELISA, Flow Cytometry, Functional Studies, in vivo Research
Reactivity
Human
Host
Human
Clonality
Monoclonal
Isotype
IgG1
Conjugate
Unconjugated
Purity
The purity of this Biosimilar is >95%, as determined by SDS-PAGE.
Product Form
Liquid
Formulation
Supplied in 0.01M Phosphate Buffered Saline, pH 7.4.
Storage
Shipped at 4°C. Upon delivery store at 4°C for short-term use (1-2 weeks) or aliquot and store at -20°C for long-term use (up to 12 months).
Synonyms
T-cell immunoreceptor with Ig and ITIM domains, V-set and immunoglobulin domain-containing protein 9, V-set and transmembrane domain-containing protein 3, VSIG9, VSTM3
Dose-response for Tiragolumab Biosimilar - Anti-TIGIT Antibody - BSA and Azide free (A338767).
Publishing research using Tiragolumab Biosimilar - Anti-TIGIT Antibody - BSA and Azide free (A338767)? Please let us know so that we can list the citation on this page.
Alternative products to Tiragolumab Biosimilar - Anti-TIGIT Antibody - BSA and Azide free (A338767)